Dr. Alain Catalin Mita MD
Oncologist | Medical Oncology
9200 Pinecroft Suite 480 Spring TX, 77380About
Dr. Alain Mita is an oncologist practicing in Spring, TX. Dr. Mita specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Mita manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Carol Davila University of Medicine & Pharmacy MD
Carol Davila University of Medicine & Pharmacy 1992
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.
- Design, conduct, and interpretation of organ impairment studies in oncology patients.
- Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.
- A phase I open-label study evaluating the cardiovascular safety of sorafenib in
- Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin.
- Clinical activity of mammalian target of rapamycin inhibitors in solid tumors.
- Vascular-disrupting agents in oncology.
- A phase I, multicenter, open-label, first-in-human, dose-escalation study of the
- Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.
- A phase I study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous Azacitidine and its pharmacokinetics in patients with severe renal impairment.
- Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
- Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.
- Phase I study of intravenously administered ATI-1123, a liposomal docetaxel
- Pharmacokinetic study of aldoxorubicin in patients with solid tumors.
- Targeting Survivin Inhibits Renal Cell Carcinoma Progression and Enhances the Activity of Temsirolimus.
Clinical Trials
Dr. Alain Catalin Mita MD's Practice location
Dr. Alain Catalin Mita MD's reviews
Write ReviewRecommended Articles
- Ovarian Cancer: Remembering Coretta Scott King
The United States recently honored the memory of Martin Luther King Jr. and all that was accomplished during the Civil Rights Movement of the 1950s and 1960s. This year, King’s daughter, Bernice King, asked citizens across the nation to remember her mother as well, without whom there might not be...
- What Tests Determine Pancreatic Cancer?
Pancreatic cancer is a cancer that begins in the pancreas, which is the organ that lies behind the lower part of the stomach. This type of cancer is really difficult to diagnose and it is often detected late. In most cases, by the time this cancer is detected, it has already spread rapidly and thus...
- Holistic Treatments for Lung Cancer
Lung CancerThere are two main groups of primary lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). These two main groups are based on the way the tumors grow and spread. Lung cancer has the highest rate of death of all cancers in the US. The main causes of lung cancer...
- Comparing Male and Female Breast Cancer
All individuals are born with certain breast cells and tissue. Even though men do not have milk-producing breasts, they can still get cancer. Nonetheless, breast cancer is 100x less common among men then it is among women. The American Cancer Society estimates for breast cancer in the United States...
- What Causes Testicular Cancer?
If you were to pose this simple question to your doctor, you would get the response that science does not know for sure what triggers cancer in the testes. But if you were to dig a little deeper, you may be drawn into a discussion on chromosomes and genes, the basic building blocks of life, and how...
- New Combination Therapy for Hodgkin's Lymphoma Shows Promising Results
While there are several different types of Hodgkin’s lymphoma, more than 80% of cases of diagnosed lymphoma are non-Hodgkin’s lymphoma. Patients with non-Hodgkin’s lymphoma typically receive radiation therapy, chemotherapy, or combinations of the two. Stem cell or bone marrow transplantations...
Nearby Providers
- Dr. Asit Choksi MD8850 Six Pines Dr Spring TX 77380
- Dr. Paula D. Ryan MD, PHD9200 PINECROFT DR STE 450 SHENANDOAH TX 77380
- Dr. Anirudha Dasgupta MD920 Medical Plaza Drive Spring TX 77380
- Dr. Bhuvana Sagar MD9305 Pinecroft Dr Spring TX 77380
- Dr. Michael V. Seiden MD9200 PINECROFT DR STE 450 SHENANDOAH TX 77380
- Ms. Maria Alejandra Sosa MD25511 Budde Rd Spring TX 77380